Event

Connect with Quotient Sciences at the upcoming 14th Drug Delivery and Formulation Summit in Berlin from 31st May to 2nd June.

Schedule a meeting
Press enter to search

Suggested searches

Early Development
Candidate Selection
Late Development
ADME
Translational Pharmaceutics

Resources

Resource centre

Webinar

Strategies for Achieving Regulatory Milestones Faster

Watch our on-demand webinar featuring a customer case study from Ensysce Biosciences' CEO Lynn Kirkpatrick on choosing an integrated service provider to accelerate drug development.
Reset filters
12 / 175 resources
Webinar
Quotient Sciences and Charles River Collaboration Webinar
Watch Quotient Sciences & Charles River webinar on-demand entitled, 'Integrated Strategies for Accelerating from Discovery to IND and Beyond: Charles River & Quotient Sciences Collaboration'.
Webinar
Bioanalytical Strategies for Insulin Analogues & Other Large Peptides Using LC-MS
Learn how our physiochemical-based approach enables us to accelerate the development of bioanalytical assays for insulin analogues from Michael Blackburn, Head of Bioanalytical Method Development and Labs.
Whitepaper
The First Kilograms of GMP Drug Substance
A core component of Quotient Sciences is our integrated capabilities in drug substance process research, development, and manufacturing. All are carried out at our state-of-the-art facility in Alnwick, UK.
Article
Conference Report from the European Bioanalysis Forum Workshop: toward harmonized implementation of the ICH M10 guideline
In this report, the European Bioanalysis Forum shares the proposals for harmonized implementation of the ICH M10 guideline on bioanalytical method validation and study sample analysis from the ICH M10 workshop.
Whitepaper
Synthesis to Clinic: A streamlined approach to 14C human ADME studies
We are a leading provider of 14C-enabled drug development programs, successfully conducting over 350 human ADME and other radiolabeled programs to date. Learn about Synthesis-to-Clinic®.
Scientific Posters
The use of electrospraying as a means of drug loading into mesoporous silica particles for enhanced dissolution
The use of electrospraying as a means of drug loading into mesoporous silica particles for enhanced dissolution, presented at the 13th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical (PBP) Technology 2022
Webinar
Navigating the Small Molecule CMC Pathway
Learn about drug substance and formulation considerations for improving downstream clinical outcomes. Access on demand.
Scientific Posters
A Decade of Human ADME at Quotient Sciences: Reviewing Key Study Design Variables and Outcomes
A Decade of Human ADME at Quotient Sciences: Reviewing Key Study Design Variables and Outcomes.
Scientific Posters
Safety, tolerability, and pharmacokinetics of the oligomer modulator anle138b: a first-in-human randomised, double-blind, placebo-controlled Phase 1 trial
Safety, tolerability, and pharmacokinetics of the oligomer modulator anle138b: a first-in-human randomised, double-blind, placebo-controlled Phase 1 trial
Scientific Posters
Understanding the Absorption, Metabolism and Excretion of Masitinib in Healthy Male Subjects
Understanding the Absorption, Metabolism and Excretion of Masitinib in Healthy Male Subjects.
Peer Reviewed Publication
Practical and operational considerations related to paediatric oral drug formulation: An industry survey
Practical and operational considerations related to paediatric oral drug formulation: An industry survey.
Scientific Posters
ESMO Immuno-Oncology Poster - Hubro Therapeutics QSC204718 (Vaccine Study)
A Phase I Study of the Cancer-specific Vaccine FMPV-1 in Healthy Male Subjects to Assess Safety and Immune Response